Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Endometrial Cancer - Advanced
Trial Name: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed By Carboplatin and Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma.
Protocol ID: GOG-0258
Enrollment: • About 804 people will take part in this study at several medical centers.
Taking part in this study may or may not make your health better. While doctors hope radiation therapy and chemotherapy will be more useful against cancer compared to chemotherapy alone, there is no proof of this yet. We do know that the information from this study will help doctors learn more about cisplatin plus radiation therapy, followed by carboplatin and paclitaxel as a treatment for cancer.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Jun 3, 2011
Updated: Jan 18, 2013